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Summary Molecular changes associated with breast cancer progression were characterized using the MCF-1OF cell series. MCF-1OF was
established from fibrous mastectomy tissue of a patient without detectable cancer. In vitro treatment of MCF-1OF cells with benzo(a)pyrene
resulted in a transformed subclone MCF-1OF-BP1 (BP1). Transfection of clone BP1 with T24-Hras resulted in the tumorigenic line MCF-1OF-
BP1-Tras (BP1-Tras). Using flow cytometry, the expression of HLA I, ERBB-2 and MUC-1 was found to be comparable in 'normal' MCF-1OF,
transformed BP1 and tumorigenic BP1-Tras cells. Glycosylated mucin is elevated in BP1 but reduced in BP1-Tras cells. Using mRNA
differential display analysis, cDNA profiles of the 'normal', transformed and tumorigenic cell lines were strikingly similar, yet distinct and
elevated expression of several common cDNA fragments was detected in BP1 and BP1-Tras when compared with MCF-1OF cells. These
fragments were cloned and sequenced. The sequences of clones Ti-360 and C4-310 are homologous to two reported EST cDNA clones
from human fetal tissue and were further characterized. Elevated expression of the genes corresponding to clones Ti -360 and C4-310 was
verified using Northern blotting. High-level expression of these genes was also detected in the breast cancer cell line MCF-7 that was derived
from the pleural effusion of a patient with advanced breast cancer. Therefore, specific molecular changes associated with breast cancer
development were identified and may be indicators of neoplastic progression.
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Neoplastic progression is a prolonged and stepwise process and
tumour growth occurs after a series of molecular alterations that
culminate in tumorigenesis (Foulds, 1975; Pitol and Dragan,
1991). Particular breast lesions have been associated with
increased risk of cancer development. Women with carcinoma in
situ have high risk (eight to ten times) and women with atypical
hyperplasia have moderate (five times) risk of developing breast
cancer (Page et al, 1985; Page and Dupont, 1990). The correlation
of particular lesions with cancer development suggests that
specific genetic alterations in the early lesion may dictate tumori-
genesis. Identification of such molecular changes will provide
tools for the diagnosis, prognosis and treatment ofbreast cancer.
A handful ofmolecular changes have been previously associated
with breast cancer, including reduced level of class I major histo-
compatibility antigen (HLA I) (Wright et al, 1992), amplification of
ERBB-2, which is a transmembrane tyrosine kinase and a member
of the epidermal growth factor receptor family (Bargmann et al,
1986; Gusterson et al, 1992; Toikkanen et al, 1992), prolific and
uniform expression ofmucin as well as underglycosylation ofthese
mucin molecules to expose the protein backbone (Girling et al,
1989; Finn et al, 1995). Changes in HLA I and mucin may be the
consequence rather than the cause of neoplastic progression.
Molecular events critical to breast cancer progression besides
ERBB-2 amplification are still poorly understood.
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In this study, molecular alterations associated with neoplastic
progression of the breast epithelial cells were characterized. A
series of breast epithelial cell lines have been derived from
mastectomy tissue from a 36-year-old woman (Soule et al, 1990;
Paine et al, 1992). The resected breast tissue was fibrous with a
number of cysts and one focus of mild hyperplasia but without
invasive or in situ carcinoma. A mortal cell line MCF-lOm derived
from the tissue has a normal human diploid karyotype. A sponta-
neously immortalized cell line MCF-IOF was established from
MCF-1Om. MCF-1OF has a near-diploid karyotype and is of
luminal epithelial origin (Pauley et al, 1993).
MCF-lOF cells were cultured with 0.2 ,ug ml-' benzo(a)pyrene
at 37°C for 24 h and a clone MCF-lOF-BPl (BPI) was generated
that has reduced doubling time and forms anchorage-independent
colonies when grown in soft agar (Calaf and Russo, 1993; Calaf
et al, 1995). A subclone, BPI-E, developed significantly larger
colonies in the agar. BP1-E cells injected into the mammary fat
pads of severe combined immunodeficient (SCID) mice formed
palpable lesions in 2-3 months, which were histologically adeno-
carcinoma but did not grow progressively. BPI cells were trans-
fected with human T24-Hras to generate BP1-Tras, which
produced consistent and progressively growing tumours in the
mammary fat pads of SCID and nu/nu beige mice (Calaf and
Russo, 1993; Calaf et al, 1995). As BPI and BPl-Tras cells are
benzo(a)pyrene O- - BP1-E
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Figure 1 Derivation of preneoplastic and neoplastic breast epithelial cell
lines
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Figure 2 Flow cytometric analysis of MCF-1OF, BP1, BP1-E, BP1-Tras and SKBR-3 cells. Single-cell suspensions were prepared from monolayer cultures and
stained with MAb W6/32, TA-1, BC-2 or SM-3 directed to class HLA, ERBB-2, glycosylated and non-glycosylated MUC-1 respectively. Normal mouse Ig (NMIg)
was the negative control and FITC-conjugated goat anti-mouse IgG was the secondary antibody. The shaded curves in A-E represent the staining profiles of
MCF-1OF cells
subclones of MCF- 1OF, they are expected to share the same
phenotypes and mRNA profiles. Molecular alterations that arose
and persisted through neoplastic progression may be critical to
tumorigenesis and are identified by comparing the mRNA profiles
ofMCF-IOF, BP1, BPI-E and BPI-Tras.
MATERIALS AND METHODS
Human breast epithelial cell line series
MCF-IOF cell series (Figure 1) were derived from breast tissue
that was removed in 1984 by mastectomy from a patient without
evidence of neoplasia. The cell lines tested in this study include
the spontaneously immortalized, near-diploid MCF-IOF, benzo-
(a)pyrene-treated BPI, a BPI subclone BPI-E and a tumorigenic
BPI-Tras, which was derived from BPI by T24-Hras transfection.
To date, the patient is free of neoplastic disease. The cell lines are
maintained in a 1:1 mixture of Dulbecco's modified Eagle and
Ham's F12 media (DMEM/F12, Gibco, Grand Island, NY, USA)
supplemented with 5% horse serum, 4 mM L-glutamine, 10 ,ug ml-'
insulin, 500 ng ml-' hydrocortisone, 100 ng ml-' cholera toxin
(Calbiochem, San Diego, CA, USA), 10 ng ml-' recombinant
epidermal growth factor (EGF, Calbiochem), 100 U ml-' penicillin
and 100 gg ml-' streptomycin.
Human breast cancer cell line MCF-7 was established in 1973
from the pleural effusion of a patient with advanced breast adenocar-
cinoma (Soule et al, 1973). MCF-7 is maintained in super-enriched
Dulbecco's modified Eagle medium (SDMEM) supplemented
with 4% heat-inactivated fetal bovine serum (HyClone, Logan,
UT, USA), 10% NCTC 109 medium (Sigma, St Louis, MO, USA),
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Figure 3 Differential display of RNAs from MCF-10F (1), BP1-E (2) and BP1-Tras (3) cell lines. Total RNA was isolated from MCF-10F, BP1-E and BP1-Tras
cells and treated with RNAase-free DNAase (Promega, Madison, WI, USA) to remove genomic DNA contamination. RNA was reverse transcribed with
5'T12MG primer (M is a degenerate mixture of dA, dC and dG) using MoMuLV reverse transcriptase. The RT product was amplified with 5'T12MG and the
specified AP primer for 40 cycles. The PCR product was electrophoresed in a 6% PAGE gel. [32P]ATP T4 polynucleotide kinase end-labelled, Mspl-digested
pBR322 DNA was included as a size standard. Migration of the 622-, 527-, 404-, 307-, 242-, 238- and 217-bp fragments from top to bottom are indicated at the
left margin
mg ml-' bovine crystalline insulin (Sigma), 1 mm oxalacetic acid,
0.5 mm sodium pyruvate, 2 mM L-glutamine, 0.1 mM MEM non-
essential amino acids, 100 units ml-' penicillin and 100 jig ml-
streptomycin.
Flow cytometric analysis
Cells in monolayer culture were suspended by minimal treatment
with trypsin-EDTA. Expression of class I HLA was determined
using flow cytometry with MAb W6/32 directed to a constant
region of human HLA (American Type Culture Collection). MAb
TA-1, which recognizes the extracellular domain of ERBB-2, was
purchased from Oncogene Research Products (Cambridge, MA,
USA). MAb BC-2, which recognizes the glycosylated mucin, was
obtained through Dr OJ Finn (Jerome et al, 1992). MAb SM-3,
which recognizes the underglycosylated protein core of MUC-1
protein, was a gift from Dr Joyce Taylor-Papadimitriou (Imperial
Cancer Research Fund, London, UK) (Burchell et al, 1987). FITC-
conjugated goat anti-mouse IgG was the secondary antibody
(Jackson ImmunoResearch Laboratory, West Grove, PA, USA).
Flow cytometric analysis was performed with a FACStar or
FACscan (Becton Dickinson, Mountain View, CA, USA).
Differential display analysis
Total cellular RNA was isolated from monolayer cultures with
Trizol reagent (Gibco-BRL) according to the manufacturer's
instructions and treated with RNAase-free DNAase I (Promega,
Madison, WI, USA) to remove genomic DNA contamination.
Reverse transcription (RT) and polymerase chain reaction (PCR)
primers and reagents were from GenHunter Corp (Boston, MA,
USA) unless otherwise specified, and the reactions were
performed in a Perkin-Elmer 9600 Thermal Cycler (Norwalk, CT,
USA). The RT reaction contained 0.2 jg RNA and 1.0 mM
5'T12MN primer (M is a degenerate mixture of dA, dC and dG) in
20 ,ul. After heating at 65°C for 5 min, I00 EU MoMuLV reverse
transcriptase was added, the reaction was incubated at 37'C for
60 min, denatured at 95°C for 5 min and held at 4°C. One quarter
ofthe RT product was added to a 20-tl reaction containing 2.0 mM
dNTPs, 10 mCi [35S]dATP (1200 Ci mmol-'; DuPont, Boston,
MA, USA), 1 EU TaqI polymerase (Perkin-Elmer), 1.0 mM
5'T1,2MG and 0.2 mm of the specified AP-primer. Primer
sequences are AP-1: 5'-AGCCAGCGAA-3', AP-2: 5'-
GACCGCTTGT-3', AP-3: 5'-AGGTGACCGT-3', AP-4: 5'-
GGTACTCCAC-3', AP-5: 5'-GTTGCGATCC-3', AP-6:
5'-GCAATCGATG-3', AP-7: 5'-CCGAAGGAAT-3', AP-8: 5'-
GGATTGTGCG-3', AP-9: 5'-CGTGGCAATA-3', AP-10: 5'-
TAGCAAGTGC-3', AP-11: 5'-CAGACCGTTC-3', AP-12:
5'-TGCTGACCTG-3', AP-13: 5'-AGTTAGGCAC-3', AP-14: 5'-
AATGGGCTGA-3', AP-15: 5'-AGGGCCTGTT-3', AP-16: 5'-
CGTCAGTGAC-3', AP-17: 5'-GCAAGGAGTC-3', AP-18:
5'-CTGAGCTAGG-3', AP-19: 5'-GGCTAATGCC-3' and AP-20:
5'-GTGATCGGAC-3'. The PCR reaction was for 40 cycles at
94°C (30 s), 40°C (2 min) and 72°C (30 s), followed by 72°C
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Figure 4 Identification of cDNA fragments Ti -360 and C4-310 with increased expression in the transformed breast epithelial cell. (A) Differential display of
RNA from MCF-10F, BP1, BP1-E and BP1-Tras was performed as described in the legend to Figure 7. DNA fragments Ti -360 and C4-310, which were
amplified with primers T12-MT/AP-1 and T12-MC/AP4 respectively, were detected in the transformed BP1 and BP-1 Tras but not in the parental MCF-10F cells.
DNA fragments Ti -360 and C4-310 were eluted from the filter and cloned into the PCR-Trap cloning vector. (B) Northern blot analysis was performed with poly-
A RNA isolated from MCF-1OF, BP1, BP-1 Tras and breast cancer cell line MCF-7 cells. Aliquots (10 ,ug) of poly-A RNA samples were applied to a horizontal
1.2% agarose gel, separated by electrophoresis and transferred to a nitrocellulose filter with 20 x SSC. Ti -360 and C4-310 hybridization probes were labelled
by the incorporation of [32P]dCTP through polymerase chain reaction, using the LRT and RLT primers (GenHunter) flanking the insertion site of the PCR-Trap
cloning vector. Hybridization probe for glyceraldehyde phosphate dehydrogenase (GADPH) was labelled with [32P]dCTP by nick translation.
(5 min) and holding at 4°C. One-quarter of the PCR product was
mixed with loading dye, boiled, chilled and electrophoresed in a
6% polyacrylamide (PAGE) gel (Long-Ranger, AT Biochem,
Malvern, PA, USA) in 1 x TBE, at 50 volts for approximately 3 h.
The size standard was Mspl-digested pBR322 DNA end-labelled
with gamma-[32P]ATP using T4 polynucleotide kinase and
included DNA fragments of 622, 527, 404, 307, 242, 238 and
217 bp. The unfixed gel was dried and exposed to X-OMAT AR
film (Kodak, Rochester, NY, USA). The absence of DNA contam-
ination was confirmed by separate analysis of each RNA sample
under identical conditions cxcept for the exclusion of MoMuLV
reverse transcriptase.
Northern blot analysis
Polyadenylated RNA was isolated using oligo dT affinity chro-
matography. Northern blots were prepared essentially as described
previously (Sambrook et al, 1989). Aliquots (10fig) ofpoly-A RNA
were brought to 50% (v/v) formamide, 2.2 M formaldehyde, 0.5 mM
disodium EDTA and 10 mm sodium phosphate buffer (pH 7.4).
Samples were heated to 68°C for 5 min, cooled to room temperature
and adjusted to 0.05% (w/v) sodium dodecyl sulphate (SDS),
0.0025% (w/v) bromophenol blue, 5% (v/v) glycerol and 5 mM
disodium EDTA. The samples were applied to a horizontal 1.2%
agarose gel prepared in 1.1 M formaldehyde and 10 mM sodium
phosphate buffer (pH 7.4). After electrophoresis for 6 h at 50 V in
20 mM MOPS-acetate, 1 mM EDTA (pH 7.0), RNA was transferred
to a nitrocellulose filter with 20 x standard saline citrate (SSC).
Hybridization probes for glyceraldehyde phosphate dehydrogenase
(GAPDH) were labelled with [32P]dCTP by nick translation. Tl-360
and C4-310 probes were labelled by incorporation of[32P]dCTP with
PCR using the LRT and RLT primers flanking the insertion site of
the PCR-Trap cloning vector purchased from GenHunter. EST clone
72720 in pBluescript was purchased from Research Genetics
(Huntsville, AL, USA). The 72720probe was prepared by PCR with
SP6 and T7 primers that flank the insertion site.
Nitrocellulose filters containing poly-A RNA were pretreated
for 3 h in 3 x SSC and 5 x Denhardt's at room temperature. The
filters were then prehybridized in 3 x SSC, 5 x Denhardt's solu-
tion, 100,g ml-' denatured salmon sperm DNA, 0.1% SDS and
0.2 mM EDTA forapproximately 18 h at room temperature and 3 h
at 68°C. The prehybridization solution was removed and replaced
with hybridization solution containing 2.5 x 106 c.p.m. ml-' dena-
tured, radiolabelled probes. Hybridization was carried out at 68°C.
Stringent post-hybridization washes were performed in 0.1 x SSC
and 0.1Y% SDS at 60°C. Hybridized blots were exposed to
X-OMAT AR film for 4-7 days. Quantification was performed
with a Molecular Dynamics Storm phosphorimager.
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.Ag", -.72720 GAATTCGGCACGAGACTGGCTACCCTCAAAGGAAATAATGCCAAACTCACTGCAGCCCTG
72720 CTGGAGTCCACTGCCAATGTGAA-CAATGGAAACAGCAACTTGCTGCCTATCAAGAGGAA
72720 GCAGAACGTCTGCACAAGCGGGTGACTGAACTTGAATGTGTTAGTAGCCAAGCAAATGCA
72720 GTACATACTCATAAGACAGAATTAAATCAGACAATACAAGAACTGGAAGAGACACTGAAA
72720 CTGAAGGAAGAGGAAATAGAAAGGTTAAAACAAGAAATTGATAATGCCAGAGAACTACAA
T1-360 GCCAGCGAACTACAA
72720 GAACAGAGGGATTCTTTGACTCAGAAACTACAGGAAGTAGAAATTCGGAACAAAGACCTG
Ti-360 GAACAGAGGGATTCTTTGACTCAGAAACTACAGGAAGTAGAAATTCGGAACAAAGACCTG
72720 GAG GACAACTNTCTGACTTAGAGCA NCGTCTGGAG.AAAGTCAGAATGAACAAGAAGCT
TT-360 GAGGGACAACTGTCTGACTTAGAGCAACGTCTGGAGAAAAGTCAGAATGAACAAGAAGCT
72720
Tl -360
TTTCGCAATAACCTGAAGACACTCTTAGAAATTCTGGATGGAAAGATATTTGAACTAACA
TTTCGCAATAACCTGAAGACACTCTTAGAAATTCTGGATGGAAAGATATTTGAACTAACA
72720 GAATTACGAGATAACTTGGCCAAGCTACTAGAATGCAGCTAAGGAAA-GTGAAATTTCAG
**+X****************** ************
T1-360 GAATTACGAGATAACTTGGCCAAGCTACTAGAATGCAGCTAAGGAAAAGTGAAATTTCAG
72720 TGCCAATTAATTAAAAGATACACTGTCTCTC-TTCCATAGGACTGTTTAGGCTCCTGCAT
T1-360 TGCCAATTAATTAAAAGATACACTGTCTCTCCTTCCATAGGACTGTTTAGGCTCCTGCAT
72720 CCAAGAATTGCCAAAAAAAAAAAA
Ti -360 NCAAGAATTGCACAAAAAAAAAAAA
Figure 5 Sequence analysis of clones Ti-360 and 72720. *Identical nucleotides in clones Ti-360 and 72720
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DNA sequencing
DNA fragments Tl-360 and C4-310 were amplified using PCR
with LRT and RLT primers flanking the insertion site of the PCR-
Trap cloning vector. PCR products were separated by electropho-
resis through 1% NuSieve gels (FMC, Rockland, ME. USA) in
TAE buffer and stained with 0.1% ethidium bromide. DNA was
visualized with a UV transilluminator, the band removed and DNA
recovered with Qiagen columns. Sequencing, was carried out using
both LRT and RLT primers with an ABI model 363A automated
sequencer at the Center for Molecular Medicine and Genetics
Sequencing Facility. Wayne State University. EST clone 72720
was sequenced with SP6 and T7 primers that flank the insertion
sites using the cDNA clone as the template.
RESULTS
Phenotypic characterization of MCF-1OF cell series
The expression of HLA I, ERBB-2 or MUC- I is altered in some
breast cancer cells and their expression in MCF-1OF cell series
was measured using flow cytometry (Figure 2). The levels of HLA
I determined by the binding of MAb W6/32 directed to a common
region in HLA I was similar in MCF-IOF. BPI, BPI-E and BPI-
Tras, showing the preservation of HLA I after in vitro transforma-
tion. Basal level of ERBB-2 expression was detected in all test
samples by MAb TA-1, which recognized an extracellular domain
of ERBB-2. indicating that transformation of MCF-IOF was not
associated with ERBB-2 amplification. Glycosylated mucin recog-
nized by BC-2 was elevated in the transformed BP-1 and BP-IE
but reduced in tumorigenic BPI-Tras cells. None of the test
cells expressed underglycosylated mucin (MUC-1), which is
recognized by MAb SM-3. Breast cancer cell line SKBR-3 was
suspended from monolayer culture by the same treatment with
Trypsin-EDTA and stained with MAb W6/32, TA-1, BC-2 and
SM-3. Elevated expression of ERBB-2, glycosylated mucin
and underglycosylated mucin was detected in SKBR-3 cells.
Therefore, unlike SKBR-3 cells, transformed and tumorigenic
MCF-lOF-derived cells demonstrated little or no enhancement in
these molecules.
MRNA differential display
The enhanced anchorage-independent growth and tumorigenicity
of BPl-Tras cells indicated that critical genetic events occurred
after benzo(a)pyrene treatment and T24-Hracis transfection (Calaf
and Russo, 1993). Alteration in HLA-I, ERBB-2 and mucin protein
expression was, however, not detected and may not be critical to the
neoplastic progression of MCF-IOF cells. To identify the events
that are associated with neoplastic progression, it was necessary to
define alteration in gene expression and mRNA differential display
was used. RNA transcripts from MCF-1OF and its transformed
derivatives were reverse transcribed. cDNA was amplified using
PCR with primer T12MN, which hybridizes with the poly-A tail,
and a set of random primers that were designed to encompass all
mRNA sequences. The profiles of the PCR products from MCF-
IOF and its derivatives are strikingly similar. Figure 3 is an example
of PCR products amplified from the RNA of MCF-IOF, BP1-E and
BPI-Tras using 5' primer T, MG and 3' random primers AP-1-AP-
5. The same RNAs were independently evaluated three times; each
analysis produced essentially identical results. Samples that were
not reverse transcribed did not produce any detectable product,
indicating the absence of DNA contamination (data not shown).
The majority of RNA species are common among the three cell
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0 Cancer Research Campaign 1998239655 AACTGAATAAACCATTAACTGGCCATCCTGGTTTTGCAGAGATCAGGTTGTTGACAGTTC
239655 CTGGTTGACCCACAGCTACCCATGTCAGTTATCTCCACTAACATATCCAAGAATCTTTGT
C4-310 CTCCACTAACATATCCAAGAATCTTTGT
239655 AGGACAATTTCTCCACCTGCAAGGTCTTTCAGGTAGAACTCTTCTTTTAAGGCAATTAGC
C4-310 AGGACAATTTCTCCACCTGCAAGGTCTTTCAGGTAGAACTCTTCTTTTAAGGCAATTANC
239655 CCATTGCCAAAAGGTTTTACTGTCTTAAAGCTGTCTTTCTGAGATCTAATTCCAAGGACT
* * * * * * * * * * * * * * * * * * * * * * * A ir * * X * * X * * X * * * * X * X * * * * * * X * X * * * * * * *
C4-310 CCATTGCCAANAGGTTTTACTGTCTTAAAGCTGTCTTTCTGANATCTAATTCCNAGGACT
239655 TCTCCACAGCTAAGTGAGATGCCTCACACCATTAGGTGATGCTTTGGACAGAACAGAGTA
C4-310 TCTCCACAGCTAAGTGAGATGCCTCACACCATTAGGTGATGCTTTGGACANAACAAAGTA
239655 TTTTCATCTTGTGTTTAAAGCAATTCCTTGGCTTCGGCTCCTCACCACTTTCTATGGCCA
C4-310 TTTTCATCTTGTGTTTAAAGCAATTCCTTGGCTTCGGCTCCTCACCACTTTCTATG-CCA
239655 GTCTCCCATTTATGTCCCTAGTAAT-GCCTATGCAA
C4-310 GTCTCATTTATGTCCCTAGTAATGCATGCAAAAAAAAAA
Figure 6 Sequence analysis of clones C4-310 and 239655. *Identical nucleotides in clones C4-310 and 239655
lines, consistent with the common origin of these cells.
Interestingly, BPI-E cells contain several RNA species (arrow-
heads) not expressed in the parental MCF-1OF or tumorigenic BPI-
Tras cells. These species may represent unstable genetic alterations
that were induced by the chemical carcinogen, but were not
sustained through neoplastic progression. The mRNA species that
are overexpressed in both transformed and tumorigenic cells may
encode proteins that provide growth or survival advantages. To
characterize the overexpressed mRNA species that were sustained
through neoplastic progression, a comprehensive series ofdifferen-
tial display analysis was performed. RNA was isolated from MCF-
IOF, BP- 1, BP- I E and BP -Tras, reverse transcribed and amplified
with the complete set of four 3' T12MN primers and twenty 5'
random 10-mers. From the entire panel of PCR products, 16 PCR
fragments that demonstrated consistent, elevated expression in both
BPI and BPl-Tras were eluted from the filter, reamplified using
PCR, and the product size confirmed by gel electrophoresis (not
shown). Verified products were cloned into PCR-TRAP cloning
vector and the inserted DNA fragments were sequenced. Two ofthe
clones T1-360 (amplified by TI2MT and AP1) and C4-310 (ampli-
fied by TI2MC and AP4) have been further characterized.
Differential expression of mRNA corresponding to T1-360 and
C4-3 10 was verified using Northern hybridization (Figure 4).
Poly-A+RNA was isolated from MCF-IOF, BPI, BPl-Tras and a
breast cancer cell line MCF-7 derived from the pleural effusion of
a patient with metastatic breast cancer. Hybridization with T1-360
probe demonstrated two discrete transcripts of 7.5 and 5.5 kb in
mRNA from BP1, BP1-Tras and MCF-7 but not from 'normal'
MCF- 1OF. Hybridization with C4-3 10 probe demonstrated a single
3.6 kb transcript expressed at tenfold excess in the tumorigenic
BPI-Tras and in breast cancer line MCF-7 when compared
with MCF- IOF cells as determined by the phosphorimager.
Hybridization with a probe for glyceraldehyde phosphate dehydro-
genase (GADPH) verified equivalent loading ofthe RNA samples.
Therefore, mRNAs containing TI -360 and C4-3 10 sequences
were significantly elevated in the transformed BPI, tumorigenic
BPI-Tras and a breast cancer cell line MCF-7 when compared
with MCF-IOF cells and may be associated with neoplastic
progression of the breast epithelial cells.
The sequence of TI-360 (Figure 5) was determined by auto-
matic sequencing. Homology with previously described cDNA
sequence was analysed using the computer program 'Basic Local
Alignment Search Tool' (BLAST) to directly access the database
including the Genebank in the National Center for Biotechnology
Information (NCBI). TI-360 was highly homologous with the
sequence of a previously described EST cDNA clone 72720 from
human fetal spleen with unknown function. Because the reported
sequence of clone 72720 was incomplete, this clone was
purchased from the Genetics Institute, resequenced and was found
to have >99% homology with the sequence of TI-360 (Figure 5).
The sequence of clone 72720 added 285 bp to the 5' end of clone
TI-360. Northern hybridization of poly-A RNA from BPI, BPI-
Tras and MCF-7 with the purchased 72720 probe produced the
same 7.5 and 5.5 kb bands (not shown), supporting the identical
nature of clone T1-360 and 72720. Therefore, the transformation
of MCF-IOF cells is associated with a sustained, elevated expres-
sion of mRNA containing the sequence of T1-360 or clone 72720.
Using the same BLAST program, the sequence of clone C4-310
showed >95% homology with another EST cDNA clone 239655
also from human fetal spleen (Figure 6). The sequence of 239655
added 92 bp to the 5' end of the C4-310 sequence. As T1-360, C4-
310 as well as the reported EST clones were all identified using the
primer 5'-TTTTTTTTTTTTMN-3' and another random primer,
the sequences represent the 3' termini with polyadenylation signal
and may contain but are not limited to the non-coding region.
Therefore, mRNAs containing TI-360 and C4-310 sequences
were expressed in the fetal tissue and were elevated in the trans-
formed breast epithelial cells.
DISCUSSION
Molecular changes that occurred during neoplastic progression of
breast epithelial cells were examined. Specific molecular changes
previously described in breast cancer cells included reduced HLA
1 (Wright et al, 1992), amplified ERBB-2 (Bargmann et al, 1986;
Gusterson et al, 1992; Toikkanen et al, 1992) and uniformly
distributed, underglycosylated mucin (Girling et al, 1989; Finn et
al, 1995). Changes in HLA I and ERBB-2 were not detected in
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MCF-IOF cell series. Because racs is activated downstream of
ERBB-2 (Xie et al., 1995), overexpression of ras may bypass the
oncogenic activity ofERBB-2. It is not surprising that tumorigenic
BPl-Tras, which was derived from BPl by transfection with T24-
Hras, did not have ERBB-2 amplification. Increased expression of
mucin was found on BP1 and BPI-E cells and was a likely conse-
quence oftransformation. Interestingly, mucin overexpression was
not observed in BP1-Tras cells, suggesting that increased mucin is
not essential for tumorigenesis and may be lost with further
neoplastic progression. Mucin on breast cancer cells is often
underglycosylated, thus exposing the protein backbone (MUC-1).
The underglycosylated MUC-1, however, was not detected in any
ofthe MCF-1OF-derived cells, suggesting that under-glycosylation
of MUC- I is not essential for neoplastic progression in vitro.
The strikingly similar profiles of cDNA fragments from MCF-
IOF cell series were expected because oftheir common origin. The
changes in mRNA expression detected by differential display
analysis, therefore, probably represented critical events that
occurred during neoplastic progression. It is of interest that several
cDNA fragments were enhanced in BP1-E but not in tumorigenic
BPl-Tras cells (Figure 3). The cause of this transient complexity
in gene expression can only be speculated. It is possible that treat-
ment with benzo(a)pyrene activated many normally quiescent
genes. Only a fraction of those gene products could provide
growth or survival advantages and enhanced expression of these
genes was expected in both transformed and tumorigenic cells.
Therefore, cDNA fragments that demonstrated elevated expres-
sion in both BPI and BPI-Tras were identified and characterized.
Approximately 20 cDNA fragments were clearly elevated in both
BPl and BPI-Tras cells, and 16 of them were cloned and
sequenced. Homologous sequences to clones T1-360 and C4-310
were found by BLAST analysis in the NCBI database and were
further characterized. Increased expression of mRNA species
containing Tl-360 or C4-3 10 sequences was verified using
Northern blot hybridization. These RNA species were of low
abundance because their detection by Northern blotting required
the use of poly-A RNA and prolonged exposure time (4-7 days).
As many genes that mediate critical cellular functions including
signal transduction are expressed at low levels, TI-360 and C4-
310 may represent such genes. Detection of changes in low-abun-
dance RNA is possible only in cell series from the same origin
such as the MCF-1OF series. In this study, expression of T1-360-
and C4-310-related genes was elevated in BP1 and BP1-Tras cell
lines when compared with the parental MCF-1OF cell. The
increased gene expression is correlated with enhanced anchorage-
independent growth of BP1-Tras>BPl>MCF-10 F (Calaf and
Russo, 1993; Calaf et al, 1995). Importantly, high-level expression
of genes containing TI-360 and C4-3 10 sequences was also
detected in a human breast cancer cell line MCF-7, supporting
their roles in human breast cancer development. Further character-
ization of these genes will provide useful tools in dissecting the
molecular events during neoplastic progression.
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